V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10335969 | 10039887 | 1.84 | 95.3 | 03 | 2018-09-12 | 2018-09-14 | Carboplatin + Vinorelbine IV | 02 | N | CARBOPLATIN + VINORELBINE | 101325059 |
| 10336057 | 10039888 | null | null | null | 2018-10-23 | 2018-11-18 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100151259 |
| 10336083 | 10039889 | 1.75 | 89.2 | Palliative (P) | 2019-04-06 | 2019-04-14 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | CLADRIBINE | 100595021 |
| 10336145 | 10039891 | 1.87 | 78.5 | Palliative (P) | 2018-01-05 | 2018-02-08 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101618248 |
| 10336167 | 10039892 | 1.64 | 45.6 | Curative (C) | 2019-06-10 | 2019-06-12 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | 02 | N | SUNITINIB | 101236519 |
| 10336195 | 10039893 | null | null | Palliative (P) | 2018-03-12 | 2019-01-20 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100606987 |
| 10336205 | 10039894 | 1.7 | null | Curative (C) | 2018-08-19 | 2018-08-20 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101294257 |
| 10336641 | 10039898 | 1.65 | 115 | null | 2018-05-14 | 2018-05-24 | FEC + DOCETAXEL | 02 | null | VENETOCLAX | 101287785 |
| 10336759 | 10039899 | 1.86 | 65.5 | null | 2021-09-04 | 2021-09-12 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 100040933 |
| 10336803 | 10039901 | 1.82 | 56.4 | null | 2018-03-11 | 2018-03-11 | Temozolomide + RT | 02 | null | TEMOZOLOMIDE | 100623473 |
| 10336953 | 10039904 | 1.68 | 66.7 | Palliative (P) | 2020-01-17 | 2020-01-20 | Sunitinib | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101396816 |
| 10337028 | 10039906 | null | null | null | 2021-12-22 | 2021-12-22 | CARBOPLATIN + VINORELBINE | 02 | Y | CARBOPLATIN + VINORELBINE | 100744810 |
| 10337070 | 10039907 | 1.59 | 71.8 | null | 2022-03-19 | 2022-04-02 | R GCVP | null | null | BUSULFAN | 100270152 |
| 10337202 | 10039908 | 1.75 | 73.3 | 03 | 2017-11-17 | 2017-12-03 | CARBOPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + VINORELBINE | 100709955 |
| 10337349 | 10039910 | 1.74 | 85.3 | null | 2018-10-18 | 2018-10-26 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100563826 |
| 10337360 | 10039911 | 1.77 | 54.8 | Adjuvant (A) | 2019-02-25 | 2019-02-25 | Cladribine (subcut) 5 days | 02 | N | CYTARABINE | 100664679 |
| 10337412 | 10039912 | 1.59 | 90 | Palliative (P) | 2021-12-09 | 2021-12-09 | Sunitinib | 02 | N | TRIAL | 100111076 |
| 10337455 | 10039913 | null | 0 | Palliative (P) | 2017-03-02 | 2017-03-04 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 100107589 |
| 10337457 | 10039914 | 1.78 | 74.6 | null | 2020-01-07 | 2020-01-22 | EOX | 02 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101242304 |
| 10337554 | 10039915 | 1.72 | 103.6 | null | 2018-12-02 | 2018-12-29 | MITOMYCIN | 02 | null | CYTARABINE | 100725354 |
| 10337591 | 10039917 | 1.58 | 70 | Curative (C) | null | 2018-11-04 | FLUOROURACIL | 02 | null | FLUOROURACIL | 101583173 |
| 10337866 | 10039918 | 1.63 | null | Palliative (P) | 2019-11-02 | 2019-11-17 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + CISPLATIN | 101017139 |
| 10337920 | 10039919 | 1.64 | 65 | 03 | 2018-04-06 | 2018-04-07 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100183596 |
| 10337954 | 10039921 | 0 | null | null | 2017-11-20 | 2017-11-25 | Carboplatin + Vinorelbine Oral | 02 | null | CARBOPLATIN + VINORELBINE | 100774395 |
| 10338059 | 10039922 | 1.86 | 61 | Palliative (P) | 2018-05-16 | 2018-05-26 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 100219080 |
| 10338095 | 10039923 | 1.52 | 85.3 | Palliative (P) | 2017-06-16 | 2018-04-05 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | CISPLATIN + FLUOROURACIL | 101412414 |
| 10338108 | 10039924 | null | null | Palliative (P) | 2018-02-10 | 2018-03-11 | Palbociclib | 02 | N | PALBOCICLIB | 100291487 |
| 10338162 | 10039925 | 1.62 | 39.35 | null | 2021-02-17 | 2021-02-21 | Palbociclib | 02 | null | PALBOCICLIB | 100912845 |
| 10338187 | 10039926 | 1.79 | 97 | 02 | null | 2017-07-20 | null | 02 | N | DARATUMUMAB | 101086184 |
| 10338334 | 10039929 | 1.77 | 72 | null | 2019-02-08 | 2019-02-08 | EOX | 01 | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101415008 |
| 10338384 | 10039930 | 1.67 | 115.5 | Adjuvant (A) | 2018-12-17 | 2019-01-11 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100163825 |
| 10338492 | 10039933 | null | null | Disease modification (D) | 2020-08-26 | 2020-08-29 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100307331 |
| 10338567 | 10039934 | 1.72 | 95 | null | 2016-10-09 | 2016-11-03 | BORTEZOMIB + THALIDOMIDE | 02 | null | BORTEZOMIB + THALIDOMIDE | 100787409 |
| 10338653 | 10039938 | 1.78 | 70 | Palliative (P) | 2017-11-27 | 2017-12-17 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100794119 |
| 10338677 | 10039939 | 1.52 | null | Adjuvant (A) | 2019-04-28 | 2019-05-04 | CARBOPLATIN + VINORELBINE | 02 | null | CARBOPLATIN + VINORELBINE | 101013846 |
| 10338781 | 10039941 | 1.82 | 64.2 | Curative (C) | 2019-03-28 | 2019-04-11 | Pazopanib | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101571657 |
| 10339027 | 10039942 | 1.63 | 0 | null | 2018-05-16 | 2018-05-29 | Cladribine (subcut) 5 days | 02 | null | CISPLATIN + VINORELBINE | 101504897 |
| 10339034 | 10039943 | 1.7 | 59.2 | Adjuvant (A) | 2018-04-16 | 2018-04-16 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100970105 |
| 10339119 | 10039944 | 1.74 | 67.5 | Adjuvant (A) | 2020-01-12 | 2020-01-13 | Trial Unspecified | null | N | CYTARABINE | 100917664 |
| 10339131 | 10039945 | 0 | 0 | Curative (C) | 2017-06-24 | 2017-07-01 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101516804 |
| 10339225 | 10039946 | null | 103 | Adjuvant (A) | 2020-09-03 | 2020-12-20 | Carboplatin + Vinorelbine Oral | 02 | N | CARBOPLATIN + VINORELBINE | 101117468 |
| 10339239 | 10039947 | 0 | null | Neo-adjuvant (N) | 2017-03-24 | 2017-03-30 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101545721 |
| 10339553 | 10039950 | 1.71 | 60 | 03 | 2020-11-05 | 2020-11-12 | null | N | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100120306 |
| 10339979 | 10039951 | 1.66 | 60 | Curative (C) | 2018-06-10 | 2018-06-23 | Palbociclib | null | N | PALBOCICLIB | 100427777 |
| 10340071 | 10039952 | 1.75 | 83 | null | 2021-10-16 | 2021-10-16 | Avelumab | Y | null | AVELUMAB | 101331481 |
| 10340425 | 10039953 | 1.75 | 77 | Palliative (P) | 2019-11-02 | 2019-11-02 | Cladribine (subcut) 5 days | 02 | null | CAPECITABINE + CISPLATIN | 100966366 |
| 10340810 | 10039955 | 0 | 0 | 03 | 2019-12-10 | 2019-12-10 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101568221 |
| 10340896 | 10039956 | null | null | Palliative (P) | 2016-11-19 | 2016-12-06 | IPILIMUMAB + NIVOLUMAB | null | N | IPILIMUMAB + NIVOLUMAB | 100793860 |
| 10341141 | 10039957 | 1.67 | 74 | Curative (C) | 2017-09-29 | 2017-09-30 | FLUOROURACIL + IRINOTECAN | 2 | null | FLUOROURACIL + IRINOTECAN | 101237121 |
| 10341272 | 10039960 | 1.83 | 85.1 | Curative (C) | 2018-05-21 | 2018-05-21 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101855062 |